{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T15:07:35Z","timestamp":1789657655706,"version":"4.0.1"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,17]]},"DOI":"10.7759\/cureus.116426","type":"journal-article","created":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:36:27Z","timestamp":1789655787000},"source":"Crossref","is-referenced-by-count":0,"title":["Plasma Cystatin C as a Marker of Acute-on-Chronic Liver Failure and 28-Day Mortality in Patients With Acutely Decompensated Liver Cirrhosis: A Prospective Observational Study"],"prefix":"10.7759","author":[{"given":"Faizudheen","family":"P","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak K","family":"Saini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Gunwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashikant","family":"Paswan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha  B","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau R","year":"2013","unstructured":"Moreau R, Jalan R, Gines P, et al.. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology. 2013, 144:1426-1439. 10.1053\/j.gastro.2013.02.042","journal-title":"Gastroenterology"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2013.03.018","article-title":"Acute kidney injury in patients with cirrhosis: perils and promise","volume":"11","author":"Belcher JM","year":"2013","unstructured":"Belcher JM, Parikh CR, Garcia-Tsao G. Acute kidney injury in patients with cirrhosis: perils and promise. Clin Gastroenterol Hepatol. 2013, 11:1550-1558. 10.1016\/j.cgh.2013.03.018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1985.205","article-title":"Limitations of creatinine as a filtration marker in glomerulopathic patients","volume":"28","author":"Shemesh O","year":"1985","unstructured":"Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985, 28:830-838. 10.1038\/ki.1985.205","journal-title":"Kidney Int"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.1994.00420020117013","article-title":"Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis","volume":"154","author":"Caregaro L","year":"1994","unstructured":"Caregaro L, Menon F, Angeli P, et al.. Limitations of serum creatinine level and creatinine clearance as filtration markers in cirrhosis. Arch Intern Med. 1994, 154:201-205. 10.1001\/archinte.1994.00420020117013","journal-title":"Arch Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1995.40","article-title":"Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine","volume":"47","author":"Newman DJ","year":"1995","unstructured":"Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int. 1995, 47:312-318. 10.1038\/ki.1995.40","journal-title":"Kidney Int"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1093\/clinchem\/46.5.712","article-title":"Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis","volume":"46","author":"Woitas RP","year":"2000","unstructured":"Woitas RP, Stoffel-Wagner B, Flommersfeld S, et al.. Correlation of serum concentrations of cystatin C and creatinine to inulin clearance in liver cirrhosis. Clin Chem. 2000, 46:712-715. 10.1093\/clinchem\/46.5.712","journal-title":"Clin Chem"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/hep.29290","article-title":"Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis","volume":"66","author":"Markwardt D","year":"2017","unstructured":"Markwardt D, Holdt L, Steib C, et al.. Plasma cystatin C is a predictor of renal dysfunction, acute-on-chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis. Hepatology. 2017, 66:1232-1241. 10.1002\/hep.29290","journal-title":"Hepatology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating glomerular filtration rate from serum creatinine and cystatin C","volume":"367","author":"Inker LA","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, et al.. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012, 367:20-29. 10.1056\/NEJMoa1114248","journal-title":"N Engl J Med"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s12072-008-9106-x","article-title":"Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL)","volume":"3","author":"Sarin SK","year":"2009","unstructured":"Sarin SK, Kumar A, Almeida JA, et al.. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL). Hepatol Int. 2009, 3:269-282. 10.1007\/s12072-008-9106-x","journal-title":"Hepatol Int"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2014-308874","article-title":"Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites","volume":"64","author":"Angeli P","year":"2015","unstructured":"Angeli P, Gines P, Wong F, et al.. Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. Gut. 2015, 64:531-537. 10.1136\/gutjnl-2014-308874","journal-title":"Gut"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0116968","article-title":"Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure","volume":"10","author":"Wan Z","year":"2015","unstructured":"Wan Z, Wu Y, Yi J, et al.. Combining serum cystatin C with total bilirubin improves short-term mortality prediction in patients with HBV-related acute-on-chronic liver failure. PLoS One. 2015, 10:e0116968. 10.1371\/journal.pone.0116968","journal-title":"PLoS One"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7272045","article-title":"Serum cystatin C predicts mortality in HBV-related decompensated cirrhosis","volume":"2019","author":"Wu J","year":"2019","unstructured":"Wu J, Wu Q, Wu M, Mao W. Serum cystatin C predicts mortality in HBV-related decompensated cirrhosis. Biomed Res Int. 2019, 2019:7272045. 10.1155\/2019\/7272045","journal-title":"Biomed Res Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i48.9432","article-title":"Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure","volume":"19","author":"Wan ZH","year":"2013","unstructured":"Wan ZH, Wang JJ, You SL, et al.. Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure. World J Gastroenterol. 2013, 19:9432-9438. 10.3748\/wjg.v19.i48.9432","journal-title":"World J Gastroenterol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3350\/kjhep.2010.16.3.301","article-title":"Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis","volume":"16","author":"Chung MY","year":"2010","unstructured":"Chung MY, Jun DW, Sung SA. Diagnostic value of cystatin C for predicting acute kidney injury in patients with liver cirrhosis. Korean J Hepatol. 2010, 16:301-307. 10.3350\/kjhep.2010.16.3.301","journal-title":"Korean J Hepatol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-51053-8","article-title":"Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis","volume":"9","author":"Jo SK","year":"2019","unstructured":"Jo SK, Yang J, Hwang SM, Lee MS, Park SH. Role of biomarkers as predictors of acute kidney injury and mortality in decompensated cirrhosis. Sci Rep. 2019, 9:14508. 10.1038\/s41598-019-51053-8","journal-title":"Sci Rep"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12074","article-title":"APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF)","volume":"14","author":"Duseja A","year":"2013","unstructured":"Duseja A, Choudhary NS, Gupta S, Dhiman RK, Chawla Y. APACHE II score is superior to SOFA, CTP and MELD in predicting the short-term mortality in patients with acute-on-chronic liver failure (ACLF). J Dig Dis. 2013, 14:484-490. 10.1111\/1751-2980.12074","journal-title":"J Dig Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/309042","article-title":"Evaluation of serum cystatin C as a marker of early renal impairment in patients with liver cirrhosis","volume":"2015","author":"Omar M","year":"2015","unstructured":"Omar M, Abdel-Razek W, Abo-Raia G, Assem M, El-Azab G. Evaluation of serum cystatin C as a marker of early renal impairment in patients with liver cirrhosis. Int J Hepatol. 2015, 2015:309042. 10.1155\/2015\/309042","journal-title":"Int J Hepatol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/534533-plasma-cystatin-c-as-a-marker-of-acute-on-chronic-liver-failure-and-28-day-mortality-in-patients-with-acutely-decompensated-liver-cirrhosis-a-prospective-observational-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:36:28Z","timestamp":1789655788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/534533-plasma-cystatin-c-as-a-marker-of-acute-on-chronic-liver-failure-and-28-day-mortality-in-patients-with-acutely-decompensated-liver-cirrhosis-a-prospective-observational-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,17]]},"references-count":17,"URL":"https:\/\/doi.org\/10.7759\/cureus.116426","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,17]]}}}